Drug induced memory disorders in the elderly;Iatrogénie et mémoire en gériatrie

Revue de Geriatrie

Volumn 30, Issue 10, 2005, Pages 715-726

  Paille, François ^a   Maheut Bosser, Anne ^a   Gerardin, Pascale ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Antidepressants; Drugs; Elderly; Iatrogenic effect; Psychotropic agent

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; CODEINE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIALGIREX; DIGOXIN; DIPYRIDAMOLE; FENTANYL; FENTANYL CITRATE; FLUOXETINE; FUROSEMIDE; GABAPENTIN; HALOPERIDOL; IBUPROFEN; ISOSORBIDE DINITRATE; IVADAL; LAMOTRIGINE; LORAZEPAM; MIANSERIN; MIDAZOLAM; NEUROLEPTIC AGENT; NICARDIPINE; NIFEDIPINE; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PHENYTOIN; PREDNISOLONE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TEMAZEPAM; THEOPHYLLINE; TIAGABINE; TIAPRIDE; UNINDEXED DRUG; VALPROIC ACID; WARFARIN; ZOPICLONE;

AGED; AGING; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG INDUCED DISEASE; HUMAN; LONG TERM MEMORY; MEMORY; MEMORY DISORDER; PRESCRIPTION; REVIEW; SEDATION; SIDE EFFECT;

EID: 31644439137     PISSN: 03977927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Doucet J, Capet C, Jégo A, Trivalle C, Noël, Chassagne P, Bercoff E. Les effets indésirables des médicaments chez le sujet âgé:épidémiologie et prévention. Presse Méd 1999;28:1789-1793.
2. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991;114:956-66.
3. Neuron, Vol44, 1, September 30, 2004.
4. Squire R, Kandel E. La mémoire de l'esprit aux molécules. De Boech Université, 2002, 282p.
5. Tulving E. Episodic and semantic memory. In:Tulving E, Donaldson W Eds. Organization of memory. Academic Press, New-York 1972.
6. Schachter DL. Amorçage et systèmes multiples de mémoire. Mécanismes perceptifs et mémoire implicite. In: Systèmes de mémoire chez l'animal et chez l'homme. Traduction B. Deweer, Eds Solal 1996.
7. Baddeley A. La mémoire de travail, théorie et pratique. PUG 1992.
8. Squire LR, Cohen NJ. Human memory and amnesia. In: Neurobiology of learning and memory. Eds Mc Gauch J, Lynch G, Weinberger N; Guilford Press NY, 1984.
9. Pancrazi MP, Azorin JM. Au carrefour du cognitif et de l'affectif:les relations entre dépression et démence. Confrontations Psychiatriques 2000;41:323-61.
10. Lechevallier N, Fourrier A, Berr C. Utilisation de benzodiazépines chez le sujet âgé:données de la cohorte EVA. Rev Epidemiol Santé Publique 2003;51:317-26.
11. Allard J, Artero S, Ritchie K. Consumption of psychotropic medication in the elderly:a re-evaluation of its effects on cognitive performance. Int J Geriatr Psychiatry 2003;18:874-78.
12. Green JF, Mc Elholm A, King DJ. A comparison of the sedative and amnesic effects of chlorpromazine and lorazepam. Psychopharmacology 1996;128:67-73.
13. Veselis RA, Reinsel RA, Feschenko VA. Drug-induced amnesia is a separate phenomenon from sedation. Anesthesiology 2001;95:896-907.
14. Lister RG, File SE. The nature of lorazepam induced amnesia. Psychopharmacology 1984;83:183-7.
15. Lucki I, Rickels K, Geller M. Psychomotor performance following the long-term use of benzodiazepines. Psychopharmacol Bull 1985;21:93-96.
16. Vignola A, Lamoureux C, Bastien CH, Morin CM. Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adult. J Gerontol B Psychol Sci Soc Sci 2000;55B:54-62.
17. Allain H, Lieury A, Belliard S, Caldwell M, Patat A, Gandon JM. Effect of drugs on mnestic performance:a methodological approach. Human psychopharmacology. 1996, vol 11, 11-19.
18. Golombok S, Moodley P, Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988;18:365-74.
19. Tata PR, Rollings J, Collins M, Pickering A, Jacobson RR. Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychol Med 1994;24:203-13.
20. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use:a meta-analysis. Arch Clin Neuropsychol 2004;19;437-54.
21. Silva A, Collao A, Orellana M, Melendez J, Caviedes P, Cardenas AM. Zopiclone, but not brotizolam, impairs memory storage during sleep. Neurosci Res 2003;47:241-3.
22. Hemmeter V, Muller M, Bischof R, Annen B, Holsboer-Trachsler E. Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology 2000;147:384-96.
23. Allain H, Bentue-Ferrer D, Tarral A, Gandon JM. Effect on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3,75 mg, and lormetazepam 1 mg in elderly healthy subjects. A randomized, crossover, double-blind study versus placebo. Eur J Clin Pharmacol 2003;59:179-88.
24. Gandon JM, Allain H. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Clin Pharmacol 2002;4:51-8
25. Loo H, Chauchot F, Galinowski A, Krebs MO, et al. Antidépresseurs. Traité de psychiatrie 1995;37-860-B-72.
26. Doraiswamy PM, Krischnan KR, Oxman T, Jenkyn LR, et al. Does antidepressant therapy improve cognition in elderly depressed patients? J Gerontol A Biol Sci Med Sci 2003;58:M1137-44.
27. Newhouse PA, Krishnan KR, Doraiswamy PM, Richter EM, Batzar J, Clary CM. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 2000;61:559-68.
28. Bondareff W, Alpert M, Friedhoff AJ, Richter EM, Clary CM, Batzar E. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000;157:729-36.
29. Cassano GB, Puca F, Scapicchio PL, Trabucchi M. Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. J Clin Psychiatry 2002;63:396-402.
30. Nebes RD, Pollock BG, Houck PR, et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatments randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res 2003;37:99-108.
31. Levkovitz Y, Caltori R, Avital A, Richter-Levin G. The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. Brain Res Bull 2002;58:345-50.
32. Van Herwaarden G, Berger HJ, Horstink MW. Short-term memory in Parkinson's disease after withdrawal of long-term anticholinergic therapy. Clin Neuropharmocol 1993;16:438-43.
33. Mori K, Yamashita H, Nagao M, Horiguchi J, Yamawaki S. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients. Pharmacopsychiatry 2002;35:6-11.
34. Tucker AR. Digoxin-related impairment of learning and memory in cardiac patients. Psychopharmacology 1983;8:86-8.
35. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999;15:15-28.
36. Rabey JM, Neufeld MY, Treyes TA, Sifris P. Cognitive effects of scopolamine in dementia. J Neural Transm Gen Sect 1996;103:873-81.
37. Pomara N, Nolan K, Halpern G. Scopolamine-induced impairment as a potential predictor of Alzheimer's disease in individuals with apolipoprotein E type 4 alleles. Neurochem Res 1995;20:1519-20.
38. Barker A, Jones R, Prior J, Wesnes K. Scopolamine-induced cognitive impairment as a predictor of cognitive decline in healthy elderly volunteers:a 6-year follow-up. Int J Geriatr Psychiatry 1998;13:244-7.
39. Tune LE, Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Disord 1999;10:342-44.
40. Martin R, Meador K, Torrentine L, Faught E, et al. Comparative cognitive effects of carbamazepine and gabapentin in healthy seniors adults. Epilepsia 2001;42:764-71.
41. Drane DL, Meador KJ. Epilepsy, anticonvulsant drugs and cognition. Baillieres Clin Neurol 1996;5:877-85.
42. Prevey ML, Delaney RC, Cramer JA, Cattanach L, et al. Effects of valproate on cognitive functioning. Comparison with carbamazepine. The Departement of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 1996;53:1008-16.
43. Read CL, Stephen LJ, Stolareck HI, Paul A, Sills GJ, Brodie MJ. Cognitive effects of anticonvulsant monotherapy in elderly patients:a placebo-controlled study. Seizure 1998;7:159-62.
44. Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003;44 (suppl 4):21-9.
45. Hill SK, Beers SR, Kmiec JA, Keshavan MS, Sweeney JA. Impairment of verbal memory and learning in antipsychotic-naive patients with first-episode schizophrenia. Schizopheria Research 2004;68:127-16.
46. King DJ. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990;157:789-811.
47. Harvey PD, Napolitano JA, Mao L, Gharabawi G. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia of schizoaffective disorders. Int J Geriatr Psychiatry 2003;18:820-9.
48. Mischara AL, Goldberg TE. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia:opening a closed book. Biol Psychiatry 2004;55:1013-22.
49. Brunnauer A, Geiger E, Laux G. Neuroleptics and cognition. Psychiatr Prax 2003;30 (suppl 2):S106-9.
50. Weickert TW, Goldberg TE, Marenco S, Bigelow LB, Egan MF. Comparison of cognitive performance during placebo period and an atypical antipsychotic treatment period in schizophrenia:critical examination of confound. Neuropsychopharmacology 2003;28:1491-1500.
51. Beuzen JN, Taylor N, Wesnes K, Wood A. A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J Psychopharmacol 1999;13:152-8.
52. Patat A, Alberini H, Bonhomme D, Soubrane C, Allain H, Gandon JM. Effects of tiapride on electroencephalograms and cognitive function in the elderly. Int Clin Psychopharmacol 1999;14:199-208.
53. Allain H, Tessier C, Bentue-Ferrer D, Tarral A, et al. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacology 2003;165:419-29.
54. Minzenberg MJ, Poole JH, Benton C, Vinogradov S. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry 2004;161:116-24.
55. O'Neill WM, Hanks GW, Simpson P, Fallon MT, Jenkins E, Wesnes K. The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain 2000;85:209-15.
56. Allen GJ, Hartl TL, Duffany S, Smith SF, et al. Cognitive and motor function after administration of hydrocodone bitartrate plus ibuprofen, ibuprofen alone, or placebo in healthy subjects with exercice-induced muscle damages randomized, repeated-dose, placebo controlled study. Psychopharmacology 2003;166:228-3.
57. Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Management 2000;19):100-8.
58. Tassain V, Attal N, Fletchek D. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain 2003;104:389-400.
59. Green HJ, Pakenham KJ, Headley BC, Yaxley J, et al. Altered-cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate:a randomized controlled trial. BJU Int 2002;90:427-32.
60. Pachet AK, Wisniewski AM. The effects of lithium on cognition:an updated review. Psychopharmacology 2003;170:225-34.
61. Denolle T, Sassano P, Allain H, Bentue-Ferrer D, et al. Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients. Fund Clin Pharmacol 2002;16:527-35.
62. Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease;systematic review and meta-analysis of observational studies. BMJ 2003;327:128.
63. In T'Veld BA, Ruitenberg A, Hofman A, Launer LJ, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-21.
64. Szekely CA, Thorne JE, Zandi PP, Ek M, et al. Nonsteroidal antiinflammatory drugs for the prevention of Alzheimer's diseases systematic review. Neuroepidemiology 2004;23:159:69.
65. Aisen PS, Schafer KA, Grundman M, Pfeiffer E, et al. Effects of rofecoxib or naproxen on Alzheimer disease progressions randomized controlled trial. JAMA 2003;289:2865-7.
66. Reines SA, Block GA, Morris JC, Liu G, et al. Rofecoxib:no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology 2004;62:66-71.
67. Yaffe K, Sawaya G, Liebenburg I, Grady D. Estrogen therapy in postmenopausal women. Effects on cognitive function and dementia. JAMA 1998;279:688-95.
68. LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition. Systematic review and meta-analysis. JAMA 2001;285:1489-99.
69. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenauposal women. The women's health initiative memory study: a randomized controlled trial. JAMA 2003;289:2663-72.
70. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenauposal women. The women's health initiative memory study: a randomized controlled trial. JAMA 2003;289:2651-62.